CARE Edge Ratings has reaffirmed the ratings across various debt instruments and bank facilities of Poonawalla Fincorp Limited (PFL), maintaining a Stable Outlook. The ratings benefit significantly from the expectation of strong, need-based support from the Cyrus Poonawalla group, whose flagship company is SIIPL. PFL demonstrated a healthy capital position, sustained asset quality improvement following Q2FY25 stress, and continued strategic alignment with the parent group.
Credit Rating Confirmation and Stable Outlook
CARE Edge Ratings announced the reaffirmation of existing ratings and the assignment of a new rating for the Perpetual Debt of Poonawalla Fincorp Limited (PFL) on March 20, 2026. The outlook for all reaffirmed instruments remains Stable. This positive action reflects PFL’s strong linkage with the parent Cyrus Poonawalla group and its improving operational metrics.
Key Ratings Summary
The reaffirmation factors in the expectation of timely support from the Cyrus Poonawalla group. Key ratings reaffirmed include:
- Long-term bank facilities: CARE AAA; Stable
- Subordinated debt: CARE AAA; Stable
- Non-convertible debentures: CARE AAA; Stable
- Perpetual Debt: Assigned CARE AA+; Stable (for the proposed ₹1,500.00 crore tranche).
- Commercial paper: CARE A1+
Ratings for instruments totaling ₹27,520.00 crore (Long-term bank facilities) and ₹13,740.90 crore (Non-convertible debentures) were reaffirmed at the highest levels.
Rationale: Group Support and Business Profile
The primary driver for the strong ratings is the perceived need-based support from the Cyrus Poonawalla group, which holds 63.95% stake in PFL via Rising Sun Holdings Private Limited (RSHPL, rated CARE AAA; Stable / CARE A1+). The group’s flagship, Serum Institute of India Private Limited (SIIPL), is a global leader in pharmaceuticals.
PFL’s business profile is characterized by a diversified product approach targeting Retail and MSME segments, including gold loans and commercial vehicle financing. Assets Under Management (AUM) stood at ₹55,017 crore (standalone) as of December 31, 2025.
Asset Quality and Capitalization Trends
While Gross Non-Performing Assets (GNPA) saw a rise in Q2FY25 due to the erstwhile small ticket personal loan book, the metric has shown reduction over the last four quarters, indicating comfortable overall asset quality. The company has shown a gradual recovery in profitability from Q2FY25, supported by operational recalibrations.
The rating also acknowledges the recent equity infusion of ₹1,499.98 crore by promoters in September 2025, which strengthens the capitalisation profile. Overall gearing remains within manageable limits.
Rating Sensitivities
Potential negative rating actions could stem from:
- Weakening of linkages with the parent group.
- Overall gearing exceeding 5x on a sustained basis.
- Net Non-Performing Assets (NNPA) remaining above 2% sustainably.
- Any sustained deterioration in profitability.
Key Weakness: Scale and Monitoring
While the scale is growing, it remains relatively moderate. The company’s ability to profitably scale up new product lines while maintaining asset quality under check remains a key monitorable for the rating agency.
Source: BSE
